Greenland Mines Ltd.
NASDAQ Global MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Greenland Mines Ltd is a Nasdaq-listed strategic minerals explorer and developer focused on natural resources and cell and gene therapies. The company operates in two main divisions: Natural Resources, pursuing exploration and development opportunities in palladium, gold, and platinum deposits, including the Skaergaard Project in Southeast Greenland; and Cell and Gene Therapy, advancing biologic, cell, and gene therapies targeting neurodegenerative and age-related diseases such as Alzheimer's, ALS, and Parkinson's. Greenland Mines is headquartered in Frankfurt am Main, Germany, and established in 2019; it maintains geographic reach across Greenland, North America, Europe, and selected global markets through strategic partnerships and investor relations channels. The company’s principal products and services span mineral exploration and development activities, precious and strategic metal resource opportunities, and early- to mid-stage clinical and translational therapy programs, including partnerships with biomedical entities to advance KLTO-202 for ALS and related indications. Core offerings are organized as: mineral exploration rights and project development services; resource delineation, feasibility studies, and permitting support; project finance and investment opportunities for mineral assets; and research, development, and potential commercialization of cell and gene therapies in preclinical and clinical stages; and corporate services including investor outreach, strategic alliances, and licensing opportunities. Greenland Mines’ recent major changes include forming and expanding strategic alliances to accelerate mineral asset development in Greenland and associated jurisdictions, pursuing acquisitions and partnerships to broaden its asset base in lithium and rare earths, launching new programs or pilots in high-potential districts, and pursuing potential corporate restructurings to align with growth objectives; these actions reflect a shift toward accelerated value creation through asset diversification, enhanced capital deployment, and advancement of pipeline therapies. The company’s business segments address both commodity markets and biotechnology, with target markets comprising institutional investors, mining and metals customers, pharmaceutical and biotech partners, and governmental and regulatory bodies. Subsidiaries and parent relationships are oriented toward maintaining a public listing while leveraging strategic joint ventures and alliance agreements to maximize project value and therapy program progression. Greenland Mines’ operations are anchored in Greenland’s mineral districts, with ancillary activities in Canada and other jurisdictions to support project financing, regulatory compliance, and potential downstream opportunities; the company emphasizes geographic accessibility, robust governance, and transparent disclosure in line with Nasdaq-listed peers. This combined approach positions Greenland Mines as a dual-sector platform aiming to generate returns from high-value mineral discoveries while advancing novel therapeutic modalities for neurodegenerative and age-related diseases.
Company News
Greenland Mines Shares Begin Trading on Xetra in Germany
Greenland Stocks Rally as Trump Teases 'Massive' Oil Hunt
Greenland Mines Applauds President Trump's Focus on Greenland Mineral Exploration, Reinforcing Its Importance to U.S. and Allied Security
Greenland Mines Authorizes $20 Million Share Repurchase Program and Announces Capital Allocation Priorities
AnorTech Secures Strategic Cornerstone as Greenland Mines Doubles Stake to 19.9%
Greenland Mines Doubles AnorTech Stake to 19.9%; Extends Critical-Minerals Platform to Smelter-Grade Alumina, Lunar Construction Materials
Greenland Mines Identifies Critical Minerals Additions Including Gallium and Vanadium as Landmark 2026 Skaergaard PGM Program Concludes
Greenland Mines Brings Total New Capital to Over $59 Million with Above-Market Raise from Existing Shareholders
Greenland Mines Expands European Investor Access with Frankfurt Stock Exchange Listing
Robust Investor Support Positions Greenland Mines for Long-Term Rare Earth Growth
IBN Announces Latest Episode of The MiningNewsWire Podcast featuring Dr. Bo Møller Stensgaard, President of Greenland Mines Ltd.
Greenland Mines Completes $12-Per-Share Equity Financing, Fully Funded Through 2027 Milestones with $42 Million, Terminates ATM, and Completes Sarfartoq Rare Earth Field Program
Greenland Mines Ltd. (NASDAQ: GRML) Applies to More than Double Mining Footprint in West Greenland
Greenland Mines Applauds Formal Signing of U.S.-Denmark-Greenland Security Agreement at United Nations
Greenland Stocks Explode After Trump's Denmark Deal — GRML Up 245%
Greenland Mines More Than Doubles Control Position in the Sarfartoq Rare Earth Magnet District in West Greenland
Rare Earth Stocks Soar After Trump's Greenland Security Announcement
Greenland Mines Applauds Historic U.S.-Denmark-Greenland Security Agreement, Reinforcing Greenland's Strategic Importance to the United States
Greenland Mines Forms Strategic Advisory Board With Three Industry Leaders to Accelerate Project Development and Western Critical-Minerals Strategy
Greenland Mines Provides Progress Update on 2026 Field Programs at Skaergaard and Sarfartoq